Related Experiment Videos
Is mortalin a candidate gene for T1DM ?
Jesper Johannesen1, Angeles Pie, Allan Ertmann Karlsen
1Steno Diabetes Center, Niels Steensens Vej, Gentofte, Denmark.
Autoimmunity
|December 29, 2004
Summary
Mortalin expression differs in rat islets exposed to cytokines, suggesting a role in beta-cell destruction. However, identified mortalin gene variations were not linked to type 1 diabetes in a Danish population.
Area of Science:
- Immunology
- Genetics
- Cell Biology
Background:
- Cytokines can induce beta-cell destruction, a key factor in type 1 diabetes.
- Mortalin (Hsp70 family) is implicated in cellular stress responses and senescence.
Purpose of the Study:
- To investigate the role of mortalin in cytokine-induced beta-cell destruction.
- To determine if mortalin gene polymorphisms are associated with type 1 diabetes (T1DM).
Main Methods:
- Mortalin expression analyzed in rodent islets exposed to cytokines (IL-1beta).
- Mortalin overexpression studied in NIH3T3 cells to assess cellular survival.
- Human mortalin gene polymorphisms and a nearby microsatellite (D5S500) genotyped in a Danish T1DM cohort.
- Family-based association tests (ETDT) used to analyze genetic data.
Main Results:
- Mortalin expression was upregulated by cytokines in rodent islets.
- Differential mortalin expression observed between rat strains with varying cytokine sensitivity.
- Overexpression of mortalin in NIH3T3 cells reduced cell survival, suggesting senescence association.
- No significant association found between mortalin SNPs, haplotypes, or D5S500 microsatellite and T1DM in the Danish population.
Conclusions:
- Functional data suggest mortalin plays a role in cytokine-mediated beta-cell destruction.
- Identified mortalin gene polymorphisms are not associated with T1DM in the studied Danish population.
- Further research may be needed to explore other genetic factors or mechanisms in T1DM pathogenesis.